Navigation Links
Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
Date:12/11/2012

ATLANTA, Dec. 11, 2012 /PRNewswire/ -- Janssen Research & Development, LLC, today announced follow-up findings from an ongoing, open-label, Phase 2, single-agent study showing that in patients with relapsed or refractory mantle cell lymphoma (MCL), the investigational oral agent ibrutinib (PCI-32765) resulted in an overall response rate (ORR) of 68 percent, including a complete response (CR) of 22 percent and a partial response (PR) of 46 percent. The study included both bortezomib-naive and bortezomib-exposed patients; 111 received ibrutinib and 110 were evaluable for efficacy. Median follow-up time was 9.2 months, with a range of time to response to treatment of 1.4 to 16.4 months.

The results were presented by lead investigator Michael L. Wang, M.D., associate professor in the Department of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center, at the 54th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, GA. The findings extend the preliminary results reported by the investigators last year at ASH, which showed a similar ORR of 69 percent, including a CR of 16 percent and PR of 53 percent. Results were similar between the bortezomib-naive and bortezomib-exposed patients.

"With continued follow up, the overall response rate is similar to what we've reported before. In addition, the compound has presented a tolerable safety profile,"  said Dr. Wang. "The data build on our knowledge and support the continued study of ibrutinib to determine its potential role as a treatment option for patients with relapsed or refractory MCL, a population that is currently difficult to treat."

Relapsed MCL means the disease has returned after an initial partial or total remission. Refractory MCL refers to cancer that does not respond to current treatment.

Among the study's secondary endpoints, the median progression-free survival (PFS) with ibrutinib was 13.9 months. Additionally, the m
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
2. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
3. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
4. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
5. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
6. American Pacific to Release Financial Results and Hold Fiscal 2012 Year-End and Fourth Quarter Investor Teleconference
7. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
8. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
9. ObeTherapy Announces the Publication of Results Obtained with one of its Lead Compounds on a New Target for the Treatment of Obesity and Type II Diabetes
10. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
11. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 11, 2014  Major advances in radiation ... are being highlighted in a three-day Oncology Summit ... from 10-12 July, 2014.  Renowned national and international cancer experts ... practices and exchange knowledge on modern technologies making ... efficient. The Summit will address ...
(Date:7/10/2014)... , July 10, 2014  Breg, Inc., a ... has launched the FreeRunner™ knee brace with new ... from patella mal-tracking return to active lifestyles.  FreeRunner,s ... other braces, providing support when patients need it ... they don,t. Patellofemoral issues are the ...
(Date:7/10/2014)... 10, 2014 Yesterday, former Congressman ... device manufacturing facility. Rep. Kennedy and Dick ... facilitate cutting-edge research in neurological disease and treatment. ... health advocate, Garen Staglin , created One ... fundamental changes that will radically accelerate the development ...
Breaking Medicine Technology:Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2
... -- Simcere Pharmaceutical Group ("Simcere" or the "Company") ... company specializing in the development, manufacturing, and marketing ... announced the resignation of chief financial officer Mr. ... 2011. Simcere,s Board of Directors has appointed Mr. ...
... Webmedx , the third largest medical transcription service, ... U.S., today announced it has received the Best in ... Top 20 Best in KLAS Awards: Software & Professional Services ... 2010 award, the company was also rated No. 1 in ...
Cached Medicine Technology:Simcere Pharmaceutical Group Announces Resignation of CFO Frank Zhao 2Webmedx Named Best in KLAS and Ranked #1 Transcription Services Vendor for Second Year in a Row 2Webmedx Named Best in KLAS and Ranked #1 Transcription Services Vendor for Second Year in a Row 3
(Date:7/12/2014)... Praeclarus Press is excited to ... new resource for women in need of lactation support. ... away from their children. Today’s mothers receive very clear ... but often feel unsupported when it comes to balancing ... evidence-based insights, and written by Nancy Mohrbacher, an international ...
(Date:7/12/2014)... 2014 Floor-grade instrument ... out of 5. This above-average score represents favorable ... buyer negotiation power over the three years to ... “during the period, surging demand for healthcare services ... new product development, have placed upward pressure on ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Ladies, it doesn't ... out there. Those who are looking for an affordable gown ... women’s special occasion dresses) to get their dream items. Recently, ... and tea length gowns . Along with that, it is ... can enjoy the special offer; the deadline of this promotion ...
(Date:7/11/2014)... The American Association of Poison Control Centers and ... Senator Bill Nelson (D-FL) for his introduction of the ... 10, 2014. Along with fellow Senate co-sponsors, this bill ... enact rules requiring safer, child-resistant packaging for any liquid ... of the bill include: Sen. Richard Blumenthal (D-CT), Sen. ...
(Date:7/11/2014)... York, New York (PRWEB) July 11, 2014 ... http://www.transvaginalmeshlawsuithelp.com/ ) , filed against Johnson & Johnson’s ... courts, Bernstein Liebhard LLP notes that the Texas ... investigating the company’s marketing of surgical mesh products ... urinary incontinence. According to a report from kens5.com, ...
Breaking Medicine News(10 mins):Health News:Praeclarus Press Announces the Release of Working and Breastfeeding Made Simple by Nancy Mohrbacher, A Much Needed Resource For Today's Working Mothers 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Worldwide Brides-to-be: It Is Time To Show Your Beauty By Wearing A Trendy Summer Short Wedding Dress From Discount-Dress.com 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 2Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 4
... ... Honorees were Named, FRANKLIN LAKES, N.J., April 1, 2008 At ... on,Monday night, Anthony Welters, Dr. June E. Osborn and Dr. Nelson L. ... Distinguished Alumni Award, respectively., The event was held at the Union ...
... gone from an art form that largely warned against the ... drug use, according to the first systematic social science study ... is published in the April 2008 issue of Addiction Research ... drug use have increased over time, and drug references increased ...
... body fat, leaving them prone to heart disease, diabetes ... to the contrary, more than half of normal-weight Americans ... their overweight contemporaries, this makes them susceptible to heart ... says. , Men whose body fat is greater than ...
... Hundreds of Hopefuls Participating in National Casting Call ... ... In celebration of Earth Month,Whole Foods Market, the world,s ... eco-conscious,personalities were chosen from hundreds of entries to host its ...
... Fla., April 1, 2008 Valensa International,introduced ... this,year,s Natural Products Expo West Conference. This ... the,historically known benefits of cranberry with D-mannose, ... the Larch tree. The,product is available in ...
... Dispute Resolution Process is ... Expeditious Path to Final Approval -, LAVAL, QC, ... today announced that it has appealed the U.S. Food ... to,the next supervisory level under the FDA,s Formal Dispute ...
Cached Medicine News:Health News:The Changing Face of Medicine: National Medical Fellowships Annual Awards Gala Honors Three Fellows 2Health News:The Changing Face of Medicine: National Medical Fellowships Annual Awards Gala Honors Three Fellows 3Health News:Drug use increasingly glamorized in rap music, according to new study of 2-decade trends 2Health News:Drug use increasingly glamorized in rap music, according to new study of 2-decade trends 3Health News:Normal Weight Doesn't Always Equal Healthy Weight 2Health News:Normal Weight Doesn't Always Equal Healthy Weight 3Health News:Whole Foods Market(R) Announces Eco-Conscious Youth Hosts for 'Whole Earth Generation(TM)' Show 2Health News:Whole Foods Market(R) Announces Eco-Conscious Youth Hosts for 'Whole Earth Generation(TM)' Show 3Health News:Whole Foods Market(R) Announces Eco-Conscious Youth Hosts for 'Whole Earth Generation(TM)' Show 4Health News:Crannose(TM) Extra Strength Women's Health Formula Targets Urinary Tract Infections 2Health News:Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy 2Health News:Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy 3
Sub Pectoral Bra...
Bandeau Bra...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test ... Ischemia Modified Albumin (IMA®) by measuring the ... patient serum sample. First identified in the ... albumin comes in contact with ischemic tissue ...
Medicine Products: